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Background. Early onset colorectal carcinoma (CRC) is rare and has been hypothesized to be a biologically and clinically distinct
entity personifying aggressive disease and worse survival.Methods. Data for 131 patients was collected by retrospective chart review.
Cox proportional hazard model was used to compute prevalence ratios and 95% confidence intervals. Results. Early onset sporadic
CRC accounted for 32% of all CRC treated in the specified time period. The mean age was 33.3 ± 7.9 years and the male to female
ratio was 2 : 1. Colon and rectal cancers accounted for 55% and 45% of patients, respectively. 96% of rectal carcinoma patients
received appropriate therapy as opposed to 65% of colon cancers. On multivariable analysis, appropriate reception of therapy (PR
4.99; 95% CI, 1.21–20.6) and signet ring morphology (PR 2.40; 95% CI, 1.33–4.32) were significantly associated with rectal cancers
as opposed to colon cancer. Kaplan-Meier analysis revealed a trend towards inferior survival for rectal carcinoma 2 years after
diagnosis. Conclusion.A high prevalence of early onset CRC was noted in the study. A trend towards inferior survival was seen in
patients with rectal cancer. This finding raises the possibility of rectal carcinoma being an aggressive subset of young CRC.
1. Introduction
Colorectal carcinoma (CRC) is one of the most common
cancers diagnosed worldwide. It has been documented that
CRC is the second most commonmalignancy in females and
the third most common amongst males [1]. Epidemiological
data suggests a higher incidence of sporadic CRC in devel-
oped countries, with Australia and New Zealand having an
age adjusted incidence of 45.7 per 100,000 as compared to
Southeast Asia which has a reported incidence of 15.9 per
100,000 [1]. Interestingly, a rapid increase in CRC incidence
rate in economically transitioning countries has been recently
reported in the literature [2] and has been attributed to a
change in the dietary habits and physical activity patterns
superimposed on genetic predisposition.
Age is considered a major risk factor for colon cancer.
Diagnosis of CRC is a rare occurrence in patients less than 40
years. Thereafter, the incidence increases sharply with every
decade of life. In developed countries, the risk of colon cancer
is 1 in 10males after the 8th decade of life [3].The life time risk
of sporadic CRC is 5% and it accounts for 90% of the cases
diagnosed in patients above 50 years [3].
Early onset CRC accounts for around 7% of the total
CRC population in the West [4] but the problem has been
reported to be of a much greater magnitude in several Asian
and African countries [5–12]. Similarly, half of the incident
cases of CRC in the Pakistani population have been estimated
to be in young patients [13]. From this, coupled with the fact
that greater than 80% of the Pakistani population is younger
than 40 years [14], the “at-risk” population for early onset
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CRC in countries like Pakistan is much higher than the rest
of the world.
Studies from the past have shown that in low incidence
countries like Pakistan, CRC tends to be located in the distal
colon and rectum while it is more likely to be located proxi-
mally in countries where incidence is higher [15]. Further-
more, dominance of left sided tumors in the young popu-
lation has also been demonstrated in other studies [4]. This
finding is consistentwith our clinical experiencewherewe see
a large proportion of rectal cancers in our young CRC popu-
lation. The exact proportion of this subgroup of patients pre-
senting with distally located disease has however never been
reported from our region.
It has been hypothesized that early onset colorectal cancer
is a biologically and clinically distinct disease where younger
individuals have more aggressive disease and worse survival
[16, 17]. A recent population based study from Pakistan also
showed that younger patients presented with disease which
was more likely to be poorly differentiated and at a more
advanced stage at diagnosis [13]. Although there have been a
few studies regarding local experience in treatment andman-
agement of colon cancer in the past, data pertaining specif-
ically to early onset colorectal cancer is lacking. Given the
increased incidence of early onset CRC in Pakistan and
the greater “at-risk” population, this study was undertaken
to report the clinical and pathological characteristics along
with the outcome of this unique subgroup of patients
through data from a tertiary care oncology center in Karachi,
Pakistan.
2. Methods
2.1. Patients. We retrospectively collected data of patients less
than or equal to 45 years of age with newly diagnosed CRC,
presenting to the Oncology Department, Aga Khan Uni-
versity Hospital (AKUH), Karachi, between January 1, 2004,
and December 31, 2011. Patients were identified using the dis-
charge coding system. Patients with suspected familial syn-
dromes (based upon clinical history and colonoscopic find-
ings) incompletely documented histopathological reports
and with biopsy reports from other centers were excluded
from analysis.
The data was collected through chart review using a pre-
designed and coded questionnaire which had been approved
by the institutional Ethical Review Committee. Details of the
demographics, symptomatology, risk factors, family history,
histopathological features, and outcome were collected for all
patients. Histopathology and surgical records were reviewed
for tumor location, tumor grade, dissected lymph nodes,
involved lymph nodes, and presence of lymphovascular inva-
sion and perineural invasion.TheAmerican Joint Committee
on Cancer Staging System (AJCC 7th edition) was used to
stage the disease.
Follow-up records, data pertaining to therapies, and dates
of last contact were also recorded. Patients who had not
followed up for greater than 6 months were contacted on the
telephone numbers obtained from the hospital database. Any
additional information regarding outcome accrued through
this telephonic contact was incorporated into the recorded
data. A patient was labeled “lost to follow-up” if all attempts
to establish contact with him/her failed.
2.2. Statistical Analysis. Data pertaining to 131 patients, who
were found eligible for the study, were analyzed. Statistical
Package for Social Sciences (SPSS) version 19 was used to
performdata analysis whichwas reported asmean± standard
deviation for continuous variables and proportions and
percentages for categorical data. Continuous variables not
following the normal distribution were reported as medians
along with interquartile ranges. Analysis was performed on
the entire cohort followed by a subgroup analysis according
to anatomical location of the tumor (colon versus rectal).
Kaplan-Meier curves were generated for median overall
survival (OS) for both colon and rectal carcinomas which
were compared using the log-rank test.
Univariate and multivariable analysis was performed
using the Cox proportional hazard model which was used to
compute prevalence ratios and 95% confidence intervals. 𝑃
value less than 0.05 was considered significant.
3. Results
3.1. Patients. A total of 581 patients presented with newly
diagnosed CRC to our centre during the study period. Of
these 186 (32%) were younger than 45 years and 131 were
found to be eligible for analysis. Most of the patients were
diagnosed via a colonoscopy (83%), while 97 patients (74%)
had advanced disease, defined as stage III/IV, at initial
presentation.
The mean age of the study population was 33.3 ± 7.9
years.Male to female ratiowas 2 : 1.No significant genetic pre-
disposing factors (such as familial adenomatous polyposis,
Lynch syndrome) were suspected in included patients. Only
8 patients (6.1%) had a positive family history of colon cancer
but were assumed to have sporadic CRC as they did not
fulfill the Amsterdam criterion for hereditary nonpolyposis
colorectal carcinoma (HNPCC) or the clinical criteria for
familial adenomatous polyposis (FAP). The most common
clinical presentations were abdominal pain (87%, 𝑛 = 114),
weight loss (66%, 𝑛 = 86), and bleeding per rectum (52%, 𝑛 =
68). Only 29 patients (22%) presentedwith intestinal obstruc-
tion.
55% of the cohort (𝑛 = 72) had colon cancer while
the rest had presented with a diagnosis of rectal carcinoma
(𝑛 = 59). 38 patients (53%) with colon cancer had right sided
disease. The colon and rectal cancer groups were similar in
age of presentation and sex. However, bleeding per rectum
was much more common in rectal carcinomas (85% versus
25%), whereas patients with colon cancer were more likely
to present with an abdominal lump (17% versus 7%) and
intestinal obstruction (29% versus 14%) and were more likely
to have preexisting polyps (13% versus 2%) (Table 1).
3.2. Histopathological Data. On histopathology, preexisting
polyps were identified in only 10 patients (7.6%). 73 patients
(56%) had moderately differentiated carcinoma and further
50 patients (38%) had poorly differentiated carcinoma. Signet
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Table 1: Baseline characteristics of the study population.
Variables All colorectal carcinoma (𝑛 = 131) Colon cancer (𝑛 = 72) Rectal cancer (𝑛 = 59)
Age, mean (SD) 33.3 (7.9) 33.74 (8.0) 32.80 (8.0)
16–25 years (%) 24 (18) 12 (17) 12 (20)
26–35 years (%) 44 (34) 24 (33) 20 (34)
36–45 years (%) 63 (48) 36 (50) 27 (46)
Gender, male (%) 87 (66.4) 50 (69.4) 37 (62.7)
Bleeding P/R (%) 68 (51.9) 18 (25) 50 (84.7)
Abdominal lump (%) 16 (12.2) 12 (16.7) 4 (6.8)
Intestinal obstruction (%) 29 (22.1) 21 (29.2) 8 (13.6)
Stage at diagnosis (%)
Stages 1 and 2 34 (26) 22 (31) 12 (20)
Stages 3 and 4 97 (74) 50 (69) 47 (80)
Grade of tumor (%)
Grade 1 8 (6.1) 4 (5.6) 4 (6.8)
Grade 2 73 (55.7) 47 (65.3) 26 (44.1)
Grade 3 50 (38.2) 21 (29.2) 29 (49.2)
Presence of signet ring cell morphology (%) 28 (21) 6 (8) 22 (37)
Presence of polyps (%) 10 (7.6) 9 (12.5) 1 (1.7)
ring morphology was identified in 28 patients (21%), per-
ineural invasion in 21 (22%), and lymphovascular invasion in
25 (26%) of surgical specimens. 76% of patients undergoing
curative surgery had undergone appropriate lymph node
dissection (>12 nodes).
When right sided colon cancers were compared to left
sided colon cancers, no statistically significant differences
were found in histopathological characteristics between these
two groups.
On the other hand, there was a greater preponderance
of poor prognostic features such as poorly differentiated
carcinoma (49% versus 29%), signet ring morphology (37%
versus 8%), and advanced stage (80%versus 69%) in the rectal
carcinoma group as compared to patients with disease of the
colon.
3.3. Treatment. 92 patients (70%) were treated with curative
intent, while the rest had presented with metastatic disease
at diagnosis and received palliative treatment. Half of the
patients treated with curative intent had rectal cancer.
The rectal carcinoma group had a higher percentage of
patients who completed appropriate therapy (96% versus
65%) (Figure 1). FOLFOX (oxaliplatin, calcium leucovorin,
and 5-fluorouracil) was used as first line adjuvant treatment
in 87% of patients (𝑛 = 54) who received adjuvant therapy
(Figure 1).
3.4. Outcome Analysis. At the time of analysis, 61 patients
(47%) had been lost to follow-up either during or after
completion of treatment of which 36 (59%) were in remission
and 22 (41%) had progressive disease. Of the remaining 70
patients (53%) who had maintained regular follow-up, 38
patients (54%) had died, 30 (43%) were in remission, and
further 2 (3%) were still undergoing treatment.
A higher proportion of patients with colon carcinoma
were lost to follow-up when compared with the rectal
carcinoma cohort (49% versus 41%). Of the patients who
maintained regular follow-up, a higher proportion of patients
were found to be in remission in the colon cancer group (46%
versus 39%). Conversely, a higher proportion of patients with
rectal carcinoma had died at the time of analysis (58% versus
51%) (Figure 2).
The median time to progression for the 60 patients
(45.8%) who had either died or were progressing at last
follow-up was 8.25 months (IQR = 3.6–16.3 months). This
figure was 9 months for the patients with colon cancer (𝑛 =
27) and 7.5 months for the patients with rectal carcinoma
(𝑛 = 33). The median progression-free survival (PFS) in the
2 groups was not statistically different (𝑃 = 0.70).
Median OS for the entire cohort was 19 months (IQR =
12.6–33.6 months). The median OS was similar between the
right sided and left sided colonic cancer groups and was also
not statistically different between the cohorts of colon cancer
and rectal carcinoma (𝑃 = 0.58). Kaplan-Meier analysis,
however, revealed a trend towards an inferior survival for
rectal carcinoma 2 years after initial diagnosis (Figure 3).
On univariate analysis signet ring morphology, presence
of polyps, appropriate reception of therapy, poorly differenti-
ated tumor, and late stage at presentation were found signif-
icantly different between the two groups (Table 2). However,
on multivariable analysis, only appropriate reception of ther-
apy (PR 4.99; 95% CI, 1.21–20.6) and signet ring morphology
(PR 2.40; 95% CI, 1.33–4.32) remained significantly associ-
ated with rectal cancers as opposed to colon cancer (Table 2).
4. Discussion
The definition of “early onset” CRC varies in the literature.
Most have defined “early onset” as <40 years though upper
limits ranging from 30 to 50 years have been used [18].
Epidemiological surveys indicate that the incidence of col-
orectal cancers is much lower in the developing countries.
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Curative intent 
Completed appropriate treatment
Yes No
74 patients
44/46 rectal (96%)
30/46 colon (65%)
18 patients underwent 
surgery alone despite
needing neoadjuvant/ 
adjuvant treatment
2/46 rectal (4%)
16/46 colon (35%)
(Neo)adjuvant 
41 rectal
21 colon
3 rectal
9 colon
54 out of 62
patients received 
FOLFOX as the 
adjuvant regimen
8 out of 62
patients received 
other adjuvant 
regimens
A total of 30 patients 
underwent surgery alone
12 appropriately
18 inappropriately
(n = 92)
Colon (n = 46)
Rectum (n = 46)
CCRT/chemo = 62
Only surgery = 12
Figure 1: Flowchart of patients treated with curative intent.
Table 2: Univariate and multivariable analysis.
Variable Univariate analysis Multivariable analysis
PR CI PR CI
Received appropriate treatment 5.35 1.30–22.1 4.99 1.21-20.6
Signet ring morphology 2.19 1.29–3.71 2.40 1.33-4.32
Poorly differentiated tumor 1.56 0.94–2.61 —
Stage III or IV at presentation 1.37 0.73–2.59 —
Presence of polyps 0.21 0.03–1.50 —
Conversely, there have been reports that suggest a higher
incidence of early onset disease in the developing world [19].
The exact cause of this difference is not known; however,
it can be postulated that the higher proportion of younger
patients in the underdeveloped countries can be a reason for
this skewed finding [16]. However, more interesting is the
hypothesis that sporadic early onset colorectal cancer is a
biologically and clinically distinct entity, accounting for its
aggressive presentation and poorer survival [16, 17, 20].
In a meta-analysis, the proportion of young CRC patients
(less than 40 years) among all CRC patients ranged from
0.4% to 36.5% with an average of 7% [4]. The majority of
these studies were conducted in North America and Europe.
The results of this meta-analysis and several other studies
indicate that sporadic early onset colon cancer is rare in the
developed countries. On the other hand, early onset CRC
is far more common in third world countries [8, 13]. We
report a prevalence of sporadic early onset CRC of 32% at
our institution during the study period which is substantially
higher thanwhat western data suggests [4].This is also higher
than estimates from other Asian studies [7, 16, 21], although
it was comparable to that from India [8, 22].
There are several potential explanations for this interest-
ing observation. First of all this study is an institution based
study where selection bias cannot be avoided. Moreover, a
tertiary care center such as ourswould ensure greater concern
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In remission
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Figure 2: Outcome of the study population.
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Figure 3: Median overall survival for colon and rectal carcinomas.
and provide better facilities for cancer detection than those
available generally in the country.This may result in inflation
of the prevalence results derived. Secondly, the presence of
a very large proportion of the population which is “young”
[6] increases the number of “at-risk” subjects and may be
responsible for a larger number of cases.
A large collection of available data suggests that several
dietary and lifestyle factorsmay significantly contribute to the
risk of development of CRC [23]. Of these, physical inactivity,
excess body weight, and central deposition of adiposity are
established risk factors [23] and probably play an prominent
role in the pathogenesis of the disease in our population
where the prevalence of these factors is unacceptably high [5].
Westernization of the diet with resultant overconsumption of
energy and developing insulin resistance may contribute to
the prevalence in the more affluent sector of the country’s
population, while the lack of specific macronutrients and
certain other dietary ingredients in meals may play a part in
the under privileged strata [23]. Smoking early in life, which
is another established risk factor for the development of colon
cancer, may also play a part in the high incidence observed at
our institution with almost a quarter of young adults in the
country (aged 18–25) being current smokers [24]. The fact
that data on these lifestyle factors could not be collected in our
study secondary to the retrospective nature of data collection
highlights one of our limitations.
Interestingly, SEER (surveillance, epidemiology, and end
results) database analysis from 1998–2002 indicates that there
was a higher proportion of patients with early onset CRC
in Asians of Indian and Pakistani origin, despite residing in
USA for many years [25]. This finding points to a possible
genetic or epigenetic etiology for development of early onset
CRC in this specific population bearing in mind the fact that
chromosomal instability (CNI) and microsatellite instability
(MSI) do occur in sporadic cases of CRC [26, 27]. The
established increased propensity of developing a colorectal
malignancy in this particular subgroup of patients has led to
calls for revision of screening guidelines in the Asian popula-
tion to include the high risk younger age groups [13], but
current guidelines remain almost identical to those adapted
by the developed countries [28].
An almost equal prevalence of colon and rectal cancer
that we found concurred with the ratio seen in countries
which have historically been labeled as “low risk” [13, 29]. A
worse stage at presentation, poorer grade of tumor, and an
increased prevalence of signet ring morphology in our study
population were similar to those reported globally reflecting
the aggressive nature of the disease in young CRC patients
[4, 30, 31].
The fact that only 80% of patients who were planned for
curative therapy received appropriate therapy (surgical/neo-
adjuvant/adjuvant) is a matter of concern as it leaves this
young population at a higher risk for recurrence in the future.
The problem can be attributed to the fact that Pakistan is a
resource-limited country with most of the health expendi-
ture derived from out-of-pocket payment and the financial
burden incurred as a result translates into poor adherence to
standard treatment guidelines in most defaulting cases.
ThemedianOS for our cohort of young CRC patients was
19 months. Studies from neighboring countries with similar
socioeconomic status such as Nepal and India have shown a
dismal survival for young CRC patients [11, 32]. As we would
expect, the survival data is varied globally and some studies
have suggested that younger age either had no effect or a posi-
tive effect on survival [4, 31, 33–35]. However, this is debatable
and needs to be taken in context with the geographical
location, tumor biology, and appropriateness of treatment.
It is important to bear in mind that our poor survival
results may have been exaggerated to a certain extent sec-
ondary to the substandard follow-up of some of our patients
and the high lost to follow-up rate witnessed in our study
when compared to standards of the West and the well-
developed Asian countries. This is a major limitation of
all the data that comes out of Pakistan as patients in our
country are not supported by the state or insurance. In
a country where the gross national income per capita is
only $1,050 [36], patients are commonly faced with difficult
choices and usually opt not to pursue regular follow-up and
investigational visits especially if deemed “cured.” It can be
extremely challenging to stay in touch with these patients as
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a significant percentage do not have telephonic access as well.
This leaves us with incomplete data pertaining to our patients
and potential exaggeration of the poor survival we report due
to missing information on “survivors.”
During the course of the study, an interest developed to
compare the subgroups of the disease (colon versus rectal).
This idea was instigated by a previous study which concluded
that distinct mechanisms of oncogenesis may be responsi-
ble for tumors of the rectum [37]. This subgroup analysis
revealed that signet ring morphology of the tumor cells
and poorly differentiated carcinomas, which have historically
been regarded as poor prognostic factors [4, 30, 31], were
significantly more prevalent in the rectal group. Another
interesting fact that was highlighted was the statistically
significant proportion of rectal cancer patients completing
appropriate therapy as opposed to patients with colon carci-
noma.This difference probably arises from the chronology of
treatment for the two subgroups whereby rectal carcinoma
patients receive neoadjuvant therapy, whereas patients with
colon cancer undergo surgery first giving them a false sense
of security of having achieved “cure” and dampening their
motivation of pursuing adjuvant treatment.
Although the median OS was not statistically different
between the two subgroups, analysis revealed a trend towards
inferior prognosis for rectal carcinoma 2 years after ini-
tial diagnosis. This, despite the fact that a higher number
of patients in this same subgroup completed appropriate
therapy, raises the possibility of rectal carcinoma being an
aggressive subset of the young CRC population. Further
weight is added to this hypothesis by studies conducted in
the past which have shown significant difference in survival
between colon and rectal cancers [38, 39]. A Turkish study in
particular documented a 5-year survival rate of 81% for colon
cancer which was more than double that for rectal carcinoma
(39%) in patients less than 40 years of age [38]. This opens
doors to evaluate differences in genetics, biology, severity, and
prognosis of rectal cancers from colon cancers in general.
The strengths of our study include the fact that this is
the first report of young CRC patients from the country. It
is also unique in that it compares the different aspects of the
2 subgroups of CRC including the completion of appropriate
treatment and provides us with an estimate of the survival of
these patients, data regarding which is extremely scarce from
our region.
5. Conclusion
We conclude that a high incidence of early onset CRC is
noted in our study population of which almost half had rectal
disease.This group had a higher prevalence of poor prognos-
tic factors and showed a trend towards inferior prognosis 2
years after diagnosis despite the fact that a larger proportion
of these patients had completed appropriate therapy. These
findings raise the possibility of rectal carcinoma being an
aggressive subset of the young colorectal carcinoma popula-
tion. Further investigation is required to test this hypothesis.
Our results indicate that young CRC is a distinct
entity which should be identified early, possibly by modify-
ing screening guidelines in countries where incidence of
early onset colorectal cancer is high. Bench research is
also required to elucidate the genetic, pathophysiological,
and molecular characteristics of this high risk population
whereby early detection could be made through molecular
testing and the management modified accordingly.
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